Publication | Open Access
Orlistat and Antisense-miRNA-Loaded PLGA-PEG Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy
65
Citations
16
References
2016
Year
We demonstrate that orlistat in combination with antisense-miR-21 or current chemotherapy holds great promise as a novel and versatile treatment agent for TNBC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1